Skip to main content
. 2020 May 12;10:7878. doi: 10.1038/s41598-020-64577-1

Table 2.

Summary of analyses of primary and secondary outcomes.

CBT MCT Adjusted difference Using bootstrapped SD Adjusted difference using multiple imputation Including time from baseline
n Mean (SD) n Mean (SD) Mean (95% CI) p-value p-value Mean (95%CI) p-value p-value
Hamilton Depression Rating Scale
Post-treatment* 54 2.93 (3.88) 55 2.67 (4.21) −0.95 (−2.88,0.98) 0.336 0.357 −2.08 (−4.70,0.54) 0.119 0.446
Follow-up 58 3.74 (4.98) 57 2.67 (2.87) −1.61 (−3.65,0.43) 0.122 0.126 −1.99 (−4.77,0.79) 0.159 0.228
Beck Depression Inventory-II
Post-treatment* 56 8.14 (8.62) 56 4.14 (4.97) −5.49 (−8.90,−2.08) 0.002 0.002 −6.43 (−10.96,−1.91) 0.006 0.001
Follow-up 55 7.67 (10.20) 54 4.13 (5.24) −4.64 (−8.21,−1.06) 0.011 0.015 −5.61 (−10.83,−0.40) 0.035 0.025
Beck Anxiety Inventory
Post-treatment 53 6.08 (6.31) 53 3.78 (4.11) −1.51 (−4.70,1.67) 0.352 0.384 −2.52 (−6.62,1.57) 0.226 0.388
Follow-up 50 5.28 (7.30) 50 3.18 (4.04) −0.91 (−4.11,2.30) 0.579 0.601 −2.48 (−6.92,1.95) 0.271 0.730
Recovery on the BDI-II
Post-treatment (%, n) 82 52%, 43 73 74%, 54 OR = 2.42 (1.20,4.92) 0.014 0.031 NA NA 0.017§
Follow-up (%, n) 82 56%, 46 73 74%, 54 OR = 2.19 (1.05,4.54) 0.036 0.068 NA NA 0.045§
Metacognitive Questionnaire 30
Post-treatment 47 53.15 (13.21) 50 43.6 (10.97) −9.97 (−15.40,−4.54) <0.000 0.003 −8.22 (−14.80,−1.63) 0.015 0.001
Follow-up 46 49.41 (14.54) 48 44 (11.02) −5.81 (−11.19,−0.43) 0.034 0.103 −6.46 (−13.53,0.60) 0.073 0.071
Negative Beliefs about Rumination Scale
Post−treatment 47 17.91 (4.96) 51 17.27 (4.95) −1.82 (−4.13,0.48) 0.080 0.115 −1.99 (−5.17,1.18) 0.217 0.120
Follow-up 46 18.30 (6.28) 49 17.0 (4.91) −2.13 (−4.47,−0.22) 0.024 0.042 −2.95 (−6.20,0.30) 0.075 0.075
Positive Beliefs about Rumination Scale
Post−treatment 47 14.43 (6.44) 51 9.98 (1.98) −4.67 (−7.3,−2.08) <0.001 0.001 −4.31 (−7.20,−1.43) 0.004 0.001
Follow-up 47 14.04 (5.97) 49 10.61 (2.60) −3.49 (−5.95,−1.03) 0.006 0.011 −3.81 (−6.60,−1.02) 0.008 0.013
Dysfunctional Attitude Scale
Post-treatment 47 114.40 (39.13) 50 96.98 (36.99) −16.34 (−29.42,−3.26) 0.014 0.024 −18.53 (−33.77,−3.29) 0.017 0.029
Follow-up 47 112.77 (37.61) 48 93.83 (36.10) −18.55 (−31.16,−5.95) 0.004 0.009 −21.08 (−39.75,−2.41) 0.027 0.012
Young’s Schema Questionnaire
Post-treatment 46 177.83 (59.51) 50 159.8 (54.67) −16.00 (−36.93,4.92) 0.134 0.178 −20.67 (−46.99,5.65) 0.123 0.127
Follow-up 47 173.26 (66.53) 48 156.02 (53.42) −11.71 (−33.35,9.94) 0.289 0.336 −21.49 (−50.80,7.81) 0.149 0.518

*Primary outcome. Group difference from mixed effects regression, controlling for therapist, patient gender, baseline depression severity, use of psychiatric medication, marital status, education and employment. Non-completers assumed to be fails. §Non-completers assigned sample mean durations. NA = not applicable (the primary analysis includes all cases). BDI-II = Beck Depression Inventory-II.